You have been chosen to receive this valuable information. |
|
|
|
|
UPCOMING WEBINAR
Cell and Gene Therapies – Trends, Supply Chain Challenges and Solutions
Date: Thursday, March 19, 2020 | Time: 9am EDT / 2pm BST / 3pm CEST
|
|
|
Dear Eduard,
Scalability and manufacturability are two challenges that the industry faces when translating the progress of cell and gene trials into broader programs to target larger populations. Join this free webinar to learn about how to maximize the potential of your cell and gene therapy pipeline, from clinical stages to commercialization.
Topics in this presentation include:
Challenges that cell and gene therapies encounter as they progress towards their goal The need for a seamless execution of a vein-to-vein supply chain throughout the journey The precautions that manufacturers need to consider in complex therapies
|
|
|
|
Darren Dasburg
Global Head of Cell Gene Services
|
|
Jeff Stone
Senior Director
Global Program Management
|
|
|
|
|
|
XTALKS PARTNER FOR THIS EVENT
Marken is a wholly owned subsidiary of UPS. Marken is the only patient-centric supply chain organization 100 percent dedicated to the pharmaceutical and life sciences industries.
|
|
|
|
|
|
|
|
|
Xtalks, 1235 Bay St. Suite 802, Toronto, ON M5R 3K4, Canada
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of BioPharm, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
